ABSTRACT
INTRODUCTION
Porcine conceptuses initiate attachment to the uterine lumenal surface following rapid expansion of the trophectoderm on Day 12 of pregnancy [1] [2] [3] . During adhesion of the trophoblast to the uterine epithelial apical surface, a localized increase in transcapillary transport [1] as well as an overall increase in uterine blood flow occurs [4] concurrently with the increase in conceptus estrogen release [5, 6] for establishment of pregnancy in the pig.
Many of the endometrial responses evoked by the developing conceptuses resemble the acute-phase response induced during generalized tissue inflammation [3, 7] . The presence of tissue kallikrein in the porcine uterine lumen [8] suggests that bradykinin could be involved with regulation of uterine function through the proteolytic cleavage of kininogen [9] . Kinins are vasoactive peptides that are normally involved with inflammatory-associated effects such as tissue prostaglandin synthesis and release, increased blood flow, histamine release, and induction of smooth muscle contraction [10] , which are many of the same alterations that occur in the uterus during establishment of pregnancy in the pig [2, 11] . Components of the kallikreinkinin system are present in the uterus of the rat [12, 13] and mouse [14] , in which blastocyst implantation is activated by ovarian release of estrogens [15] . In addition, bradykinin ␤ 2 receptor has been localized in the uterus of the rat [16, 17] as well as the ewe [18] . The detection of kallikrein enzymatic activity in the porcine uterine lumen and endometrial gene expression [8] , as well as identification of endometrial low molecular weight (LMW) kininogen protein and gene expression (unpublished data) indicates the possible presence of an active and functional kallikreinkinin system in the porcine uterus during early pregnancy.
The objective of the current investigation was to determine the changes in bradykinin content in the porcine uterine lumen and alteration of endometrial bradykinin receptor expression during the estrous cycle and early pregnancy. Although bradykinin can affect tissues through 2 specific receptors, ␤ 1 and ␤ 2 , the ␤ 2 receptor mediates the majority of physiological effects of kinins [10] . Therefore, we evaluated the presence and alteration of endometrial bradykinin ␤ 2 receptor protein and gene expression during the estrous cycle and early pregnancy.
MATERIALS AND METHODS

Animals
Research was conducted in accordance with the Guiding Principles for Care and Use of Animals promoted by the Society for the Study of Reproduction and approved by the Oklahoma State Institutional Animal Care and Use Committee. Cyclic, Large White gilts of similar age (8-10 mo) and weight (100-130 kg) were checked twice daily for estrous behavior using intact boars. The onset of estrus was considered Day 0 of the estrous cycle. Gilts assigned to be mated were bred by fertile boars at the first detection of estrus and 12 h later.
Evaluation of Uterine Lumenal Content of Bradykinin and Endometrial Bradykinin ␤ 2 Receptor Gene Expression of Cyclic and Pregnant Gilts
Cyclic and pregnant gilts (4 animals/status per day) were hysterectomized through midventral laparotomy on Days 0, 5, 12, 15, or 18 of the estrous cycle and Days 12, 15, or 18 of pregnancy as previously described by Gries et al. [19] . Induction of anesthesia was with 2.5 ml i.m. administration of a cocktail consisting of 2.5 ml Rompun (zylazime; 100 mg/ ml; Miles, Inc., Shawnee Mission, KS), 2.5 ml Vetamine (ketamine HCL; 100 mg/ml; Mallickrodt Veterinary, Mundelein, IL) in 500 mg Telazol (tiletamine HCL and zolazepam HCL; Fort Dodge, Syracuse, NE). Anesthesia was maintained with a closed-circuit system of halothane (Halocarbon Laboratories, Riveredge, NJ) and oxygen (1.0 L/min). After exposure by midventral laparotomy, the uterine horns and ovaries were surgically removed. The incision site was closed using routine surgical pro- cedures, and gilts were treated i.m. with penicillin (20 000 IU/kg body weight).
Immediately upon removal of the uterus, a 7-to 10-cm section anterior to the uterine body was excised and opened along its antimesometrial border. Small segments (2-3 cm) of endometrium were removed from the underlying myometrium with scissors and immersed in 10% buffered formalin for 6 h at room temperature.
Uterine flushings and endometrium were collected immediately following removal of the uterus. The 2 horns were isolated, and 1 horn was flushed with 20 ml of PBS (pH 7.4), while the second horn was flushed with 20 ml of PBS containing 200 l of a protease inhibitor cocktail solution consisting of 4.5 mM EDTA (Sigma Chemical Company, St. Louis, MO), 4.5 mM 1,10 phenanthroline (Sigma), 2.5 M chicken-egg-albumin trypsin inhibitor (Boehringer-Mannheim, Mannheim, Germany), 0.8 mM hexadimethrine bromide (Sigma), and 3 M aprotinin (Boehringer-Mannheim) to prevent the rapid proteolytic cleavage of endogenous bradykinin. Uterine flushings were examined to confirm pregnancy in mated gilts. Conceptuses collected on Day 12 of pregnancy were characterized according to stage of development (spherical, tubular, or filamentous) and then were immediately snap-frozen in liquid nitrogen. Uterine flushings were placed on ice until centrifugation (3000 ϫ g, for 20 min at 4ЊC) at the laboratory and stored at Ϫ80ЊC. After flushing, the uterine horn was cut along its antimesometrial border, and endometrium was exposed for removal with sterile scissors. Endometrium was collected, snap-frozen in liquid nitrogen, and stored at Ϫ80ЊC until processed for the extraction of total RNA. Endometrium was collected, and total RNA extracted from an additional group of animals (3/status) on Day 10 of the estrous cycle and early pregnancy to evaluate bradykinin ␤ 2 receptor gene expression more completely.
Bradykinin Radioimmunoassay
The content of bradykinin in uterine flushings containing the cocktail of protease inhibitors was quantified through use of a commercial bradykinin RIA kit according to the manufacturer's recommendations (Peninsula Labs, Belmont, CA). Addition of 64, 128, 256, or 512 pg bradykinin to a uterine flushing sample produced a binding curve parallel to the standard curve ( Fig. 1) , which resulted in a recovery of 61, 138, 226, or 508 pg, respectively. The sensitivity of the bradykinin RIA assay was 2 pg/ml. Uterine flushing samples (100 l) were assayed in duplicate in a single assay with a 19.18% intraassay coefficient of variation.
Endometrial RNA Extraction and Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was isolated from endometrial tissue using TRIzol reagent (Gibco/Life Sciences, Gaithersburg, MD) as previously described [8] . Approximately 0.5 g of endometrial tissue was homogenized in 5 ml TRIzol reagent using a Virtishear homogenizer (Virtis Company Inc., Gardiner, NY). RNA pellets were rehydrated with 10 mM Tris, 1 mM EDTA pH 7.4, and stored at Ϫ80ЊC until further analysis. Total RNA was quantified spectrophotometrically at an absorbance of 260 nm, while the purity was determined based on 260:280 nm ratios. Integrity of the RNA was determined via gel electrophoresis.
Total RNA (2 g) was reverse transcribed to cDNA with Moloney murine leukemia virus reverse transcriptase-Rnase H Ϫ (M-MLV-RT) (Promega, Madison, WI) using oligo(dT) 15 primer in a Perkin Elmer Cetus (Norwalk, CT) DNA thermal cycler model 480 as previously described [20] . Quality and quantity of endometrial cDNA was checked by evaluating polymerase chain reaction (PCR) expression of glyceraldehyde-3-phosphate dehydrogenase as previously described [20] .
Bradykinin ␤ 2 Receptor Primer, Optimization, and Sequencing
Because a porcine sequence for bradykinin ␤ 2 receptor was not available when the present study was undertaken, primers to bradykinin ␤ 2 receptor cDNA were designed to regions of homology between human [21] and mouse bradykinin ␤ 2 receptor mRNAs [22] . The sequence corresponding to base pairs (bp) 668-1288 of the human bradykinin ␤ 2 receptor mRNA (GenBank accession number M88714) was used to construct the forward 5Ј-TCTACAGCTTGGTGATCTGGGG and reverse 5Ј-GTTTGTGAATCTGGCGTTCCAC primers. PCRs were carried out in 25-l volumes covered with 30 l of mineral oil. To optimize the PCR conditions, cDNA representing endometrium from all days was pooled, and 2 l was amplified with 0.6 units of Taq DNA polymerase in MgCl 2 -free buffer (Promega) and a 3 ϫ 2 ϫ 3 factorial combination of primer (50, 150, 250 nM), deoxynucleotide triphosphates (dNTPs; 50 or 100 M), and MgCl 2 (1.25, 2.50, or 3.75 mM) was evaluated as previously described [20] . The optimal conditions for endometrial bradykinin ␤ 2 receptor gene amplification were 3.75 mM MgCl 2 , 100 M dNTPs, and 150 nM primer. The resultant 621-bp PCR product sequenced by the Recombinant DNA/ Protein Research Facility at Oklahoma State University was 90% homologous to the mRNA encoding for bovine bradykinin ␤ 2 receptor (GenBank accession number AF207860) and 85% homologous to human bradykinin ␤ 2 receptor [21] . Following completion of this study, the complete mRNA sequence for porcine bradykinin ␤ 2 receptor became available in GenBank. Our endometrial bradykinin ␤ 2 receptor mRNA sequence is 95% homologous to the 682-1302 bp region of porcine bradykinin ␤ 2 receptor mRNA (GenBank accession number AB051422).
Quantitative Reverse Transcriptase-PCR
Bradykinin receptor endometrial gene expression was quantified using the one-step reverse transcriptase (RT)-PCR reaction for the TaqMan Gold RT-PCR kit (P/N N808-0233; PE Applied Biosystems, Foster City, CA). The total reaction volume of 50 l contained 100 ng of total RNA and 200 nM bradykinin receptor forward primer 5Ј-GCCTCCTACGTGGCCT-ACAG, 200 nM bradykinin receptor reverse primer 5Ј-AGTGCTTGCCC-ACGATCAC, and 100 nM fluorescent labeled bradykinin receptor probe 5Ј-AACAGCTGCCTCAACCCGCTGG. The probes were all designed from the 621-bp porcine endometrial bradykinin ␤ 2 receptor cDNA sequence that was obtained from the RT-PCR product that we submitted to the Recombinant DNA/Protein Research Facility. Although a few mismatches exist, the forward primer, reverse primer, and fluorescent probe designed to our endometrial bradykinin ␤ 2 receptor sequence cDNA corresponds to the GenBank porcine cDNA sequence (AB051422) regions of 1104-1123, 1152-1170, and 1125-1146 bp, respectively. The PCR amplification was carried out in the ABI PRISM 7700 sequence detection system (PE Applied Biosystems). Thermal cycling conditions were 50ЊC for 2 min and 95ЊC for 10 min, followed by repetitive cycles of 95ЊC for 15 sec and 60ЊC for 1 min. Ribosomal 18S RNA (18S, RNA Control Kit, 43108993E; PE Applied Biosystems) was run as a control for RNA loading.
Following RT-PCR, quantitation of gene amplification was made by setting the cycle threshold (C T ) in the geometric region of the plot after examining the semilog view of the amplification plot. Relative quantitation of bradykinin ␤ 2 receptor gene expression was evaluated using the comparative C T method described previously by Hettinger et al. [23] . The ⌬C T value is determined by subtracting the bradykinin ␤ 2 receptor C T of each sample from its ribosomal 18S C T value ( Table 1 ). Calculation of ⌬⌬C T involves using the highest sample ⌬C T value as an arbitrary constant to subtract from all other ⌬C T sample values. Fold-changes in gene expression of bradykinin receptor were determined by evaluating the expression 2
Ϫ⌬⌬Ct
. A validation of the quantitative PCR was performed with 5, 1, 0.2, 0.04, 0.008, and 0.0016 ng RNA from a selected sample of RNA using both bradykinin ␤ 2 receptor and 18S primers within the same PCR well as previously described for our laboratory [23] . Expression of bradykinin ␤ 2 receptor and 18S RNA was parallel across the dilutions of RNA (data not shown). 
Immunohistochemistry
Fixed endometrial tissue sections were dehydrated in graded ethanol changes, cleared with toluene, and embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO). Sections (5 m) were cut with an AO model 820 rotary microtome (American Optical, Buffalo, NY), placed on poly-L-lysine (Sigma)-coated slides, deparaffinized, and rehydrated for immunostaining with the Vector Vectastain Elite ABC Kit (Vector Laboratories, Inc., Burlingame, CA). Mouse anti-bradykinin ␤ 2 receptor monoclonal antibody (Research Diagnostics, Inc., Flanders, NJ) was incubated with tissue sections at a 1:100 dilution. Biotin-SP-conjugated AffiniPure goat antimouse immunoglobulin G (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA), which has minimal cross-reactivity to porcine serum proteins, was used as second antibody. Negative controls for immunostaining included exclusion of the primary antibody from incubation and preabsorption of the primary antibody with rat bradykinin receptor (Research Diagnostics). Photomicrographs were taken with a Zeiss photomicroscope (Carl Zeiss, Thornwood, NY).
Statistical Analysis
Data were analyzed by least-squares ANOVA using the general linear models of the Statistical Analysis System [24] . Due to nonnormality of the uterine flushing bradykinin concentrations across days of the estrous cycle and pregnancy, bradykinin concentrations were subjected to log transformation. The statistical model tested the effect of day on uterine flushing bradykinin concentration and endometrial gene expression of bradykinin ␤ 2 receptor during the estrous cycle. The model for analysis of reproductive status effects included the effects of day, reproductive status (cyclic and pregnant), and day ϫ reproductive status.
RESULTS
Uterine Lumenal Bradykinin Content
A day effect (P Ͻ 0.01) for total bradykinin concentration in uterine flushings during the estrous cycle was detected (Fig. 2) . During the estrous cycle, bradykinin in the uterine flushings is greatest on Day 0 (estrus), followed by a 5-fold decrease on Day 5. A moderate 2-fold increase in the concentration of bradykinin occurred between Days 12 and 18 of the estrous cycle. Pregnancy affected (P Ͻ 0.001) bradykinin concentrations in uterine flushings when compared to Days 12-18 of the estrous cycle. Effects of day ϫ reproductive status were detected for concentrations of bradykinin in uterine flushings (P Ͻ 0.05). Bradykinin concentrations in uterine flushings were 5-fold greater in pregnant gilts than in cyclic gilts on Day 12, which was followed by an 8-to 10-fold greater increase for bradykinin in uterine flushings from pregnant gilts on Days 15 and 18, respectively (Fig. 2) .
Quantitative RT-PCR of Bradykinin ␤ 2 Receptor with the ABI Prism System
Endometrial gene expression of bradykinin ␤ 2 receptor was detected on Days 0, 5, 10, 12, 15, and 18 of the estrous cycle and on Days 10, 12, 15, and 18 of pregnancy. Relative quantitative bradykinin ␤ 2 receptor gene expression was evaluated using the comparative C T (threshold cycle) method (see Table 1 ). There was an effect of day of the estrous cycle on the ⌬C T bradykinin ␤ 2 receptor mRNA expression (P Ͻ 0.001), with expression being greatest on Days 0, 12, 15, and 18 of the estrous cycle and pregnancy (Table 1) , as mRNA expression was lower on Days 5 and 10. In comparison with Day 12 of the estrous cycle, the ⌬C T bradykinin ␤ 2 receptor mRNA expression increased on Day 12 of pregnancy, but a day ϫ reproductive status effect on bradykinin ␤ 2 receptor mRNA expression only approached significance (P Ͻ 0.06; Table 1 ). Conversion of ⌬C T to fold differences (Fig. 3) illustrates the decline of bradykinin ␤ 2 receptor mRNA expression on Days 5 and 10, with the 6-fold increase in expression by Days 12-15 of the estrous cycle and pregnancy.
Immunocytochemistry of Endometrial Bradykinin ␤ 2 Receptor
No staining was detected when primary antibody to bradykinin ␤ 2 receptor was deleted from the incubation or when primary antibody was preabsorbed with bradykinin receptor (Fig. 4) . Positive immunostaining was detected in the uterine surface and glandular epithelium on Day 0 (Fig.  4) . However, only faint staining was observed on Day 5 of the estrous cycle. Immunostaining in the surface and glandular epithelia became most intense from Days 12 through 18 of the estrous cycle and pregnancy. Bradykinin ␤ 2 receptors were also detected in uterine capillaries.
DISCUSSION
Developing porcine conceptuses produce estrogens that alter uterine cellular morphology [5] , vascular permeability [1, 25, 26] , uterine blood flow [4, 6] , secretion of endometrial-derived proteins [27] , and prostaglandin release into the uterine lumen [28] .
Trophoblastic attachment to the uterine surface epithelium begins on Day 13 and continues to Day 18 of pregnancy in the pig. This noninvasive type of implantation leads to formation of the diffuse epitheliochorial placenta of the pig [2, 25] , in which embryo development is dependent upon the efficient transport of nutrients from the intact endometrium, across the placenta, and into the fetal-placental circulation. Many of the events associated with conceptus development and implantation in the mouse and rat are associated with uterine activation by estrogen and uterine changes that mirror the inflammatory process [9] . Although porcine conceptuses do not implant into the uterine tissues, they release estrogens that affect attachment of trophoectoderm to the uterine epithelium and induce the inflammatory reaction that occurs during the implantation period [1, 26] .
Identification of kallikrein in the porcine uterine lumen [8] and the substrate for kallikrein, LMW-kininogen (unpublished data) suggest that the kallikrein-kinin system is active during the period of placentation. The presence of bradykinin in the uterine flushings from pregnant gilts supports our hypothesis that kallikrein mediates release of the vasoactive nonapeptide from LMW-kininogen during early pregnancy in the pig. Because there is a clear temporal association with conceptus estrogen release and an increase in uterine blood flow during early pregnancy in the pig [29] , the release of bradykinin during early pregnancy could be involved with the increase in uterine blood flow, vascular permeability, prostaglandin release, and changes in uterine tone that occurs during early pregnancy in the pig [26, 29] .
In cyclic gilts, the uterine lumenal content of bradykinin was greatest during estrus, whereas after estrus, the large increase in uterine lumenal bradykinin content occurred only during pregnancy, when the porcine conceptuses initiate estrogen synthesis on Day 12 of gestation [5] . Estrogen receptors in the uterine endometrial surface and glandular epithelium of the pig are abundant on Days 10 and 12 of the estrous cycle and pregnancy [30] , suggesting that estrogen plays a regulatory role in endometrial release of bradykinin in the pig. Kallikrein is the key regulatory enzyme in the liberation of bradykinin from LMW-kininogen. An increase in kallikrein enzyme activity was detected in the porcine uterine lumen after Day 10 of the estrous cycle and pregnancy [8] . However, the increase in tissue kallikrein activity on Days 12 and 15 reported by Vonnahme et al. [8] was not significantly different between cyclic and pregnancy gilts. Uterine tissue kallikrein is involved with cleavage of insulin-like binding proteins on Day 12 in both cyclic and pregnant gilts [31] , which indicates that several different kallikreins may be present in the uterine lumen during early pregnancy of the pig. Kallikrein belongs to a multigene family of serine proteases, which consists of approximately 15 related genes in the rat [32] and human [33] . The kallikrein family has diverse substrate specificity and variable sensitivity to inhibitors such as aprotinin [32] , however, the genes have extensive homology to each other within and among species [10, 33] . Chan et al. [14] identified and characterized expression of 5 kallikrein genes in the embryo and uterus during implantation in the mouse, many of which were expressed in a tissue-and time-specific manner. The specific porcine uterine kallikrein involved with bradykinin release or its source was not identified in the present study. Association between kallikrein activation, release of bradykinin, and estrogen release by the conceptuses during early pregnancy suggests either an indirect stimulation of endometrial release of a different tissue kallikrein, release of a conceptus kallikrein, or both. It is possible that several different uterine kallikreins are involved with alteration of the extracellular matrix on the uterine surface during implantation in pigs as well as degradation of insulin-like growth factor binding proteins after Day 10 of the estrous cycle and the release of bradykinin from LMW-kininogen during pregnancy [31, 34] . However, we cannot overlook a direct role for conceptus synthesis of kallikrein to release of bradykinin into the uterine lumen that is different from the uterine kallikrein. Vonnahme et al. [8] reported expression of a tissue kallikrein gene by early porcine conceptuses. Expression by the pig conceptus of a kallikrein that is specific for LMW-kininogen would provide local control of bradykinin release into the uterine lumen during early pregnancy to increase prostaglandin synthesis, close the uterine lumen, increased blood flow, and alter vascular permeability [10] , all of which occur in the porcine uterus during early pregnancy [11] .
Further supporting evidence for a role of bradykinin in the establishment of early pregnancy is the presence of bradykinin ␤ 2 receptors in the uterine surface and glandular epithelia and the identification of endometrial mRNA expression for bradykinin ␤ 2 receptor during the estrous cycle and early pregnancy in the pig. Endometrial expression of bradykinin ␤ 2 receptor mRNA changed throughout the estrous cycle and increased expression after Day 10 of the estrous cycle and early pregnancy. Higher levels of bradykinin ␤ 2 receptor protein and mRNA expression during estrus suggests that estrogens stimulate bradykinin ␤ 2 receptor gene expression in the endometrium, because an increase in expression is also detected on Day 12 of pregnancy when conceptus estrogens are released to signal maternal recognition of pregnancy [3] and estrogen receptor is high in the uterine surface and glandular epithelia [30] . However, bradykinin ␤ 2 receptors were also increased during similar days of the estrous cycle, indicating that the change in receptor number is not pregnancy-specific. It is possible that bradykinin ␤ 2 receptors within the uterine surface and glandular epithelium may be negatively regulated by progesterone, because the decrease in both gene and protein expression on Day 5 is temporally associated with elevated plasma progesterone concentrations and the presence of endometrial epithelial progesterone receptors [35] . The increase in both bradykinin ␤ 2 receptor protein and gene expression in cyclic and pregnant gilts after Day 10 is associated with progesterone receptor down-regulation within the uterine epithelia [35] . Although estrogen may influence bradykinin ␤ 2 receptor expression, we hypothesize that the changes in uterine epithelial progesterone receptor modulate the timing for bradykinin ␤ 2 receptor expression in the uterine epithelium to coincide with conceptus attachment. Clearly, further studies are needed to determine the factors that regulate endometrial bradykinin ␤ 2 receptors in the pig.
Estrogen regulation of the kallikrein-kinin system appears to play an important role during implantation in the rat [17, 36, 37] . Results of the present study with gilts are consistent with evidence for modulation of bradykinin receptor expression during the period of implantation [16, 17] . It is clear that porcine endometrial bradykinin ␤ 2 receptor gene expression increases close to the period of conceptus estrogen synthesis, trophoblast elongation, and attachment of trophectoderm to the uterine lumenal epithelium in pigs. The increased expression of bradykinin ␤ 2 receptor and subsequent increase in kallikrein and bradykinin during the peri-implantation period in the present study suggests that the kallikrein-kinin system is important for the establishment of pregnancy in the pig.
